A new study from the Icahn School of Medicine at Mount Sinai reveals that Parkinson’s disease patients undergoing deep brain stimulation (DBS) often have little to no signs of Lewy pathology in the prefrontal cortex at the time of surgery, even when their disease is clinically advanced. This finding, published in npj Parkinson’s Disease, challenges long-held assumptions about the relationship between symptoms and brain changes in Parkinson’s disease.

Key Takeaways

  • Researchers analyzed brain tissue from Parkinson’s patients during DBS surgery and found minimal cortical Lewy pathology.
  • This lack of pathology occurred despite patients having longstanding, clinically advanced Parkinson’s disease.
  • The results suggest that motor symptoms may not directly correlate with the accumulation of Lewy bodies in the cortex.
  • The study raises new questions about the typical progression of Parkinson’s pathology and the role of DBS.

The Study

Researchers at Mount Sinai examined brain tissue samples taken from the prefrontal cortex of Parkinson’s patients during DBS electrode implantation surgery. DBS is a surgical treatment that involves implanting electrodes in specific brain regions to help control motor symptoms. The team looked for Lewy pathology, which includes abnormal clumps of protein called Lewy bodies that are a hallmark of Parkinson’s disease.

According to the original report, the patients in the study had been living with Parkinson’s for an average of about 10 years and had moderate to severe motor symptoms. Despite this advanced clinical picture, the researchers found little to no Lewy pathology in the prefrontal cortex tissue. This was unexpected because traditional models of Parkinson’s progression suggest that Lewy bodies spread from the brainstem to the cortex as the disease advances.

What This Means for Parkinson’s Research

The findings suggest that the relationship between Parkinson’s clinical symptoms and the underlying neuropathology may be more complex than previously thought. The prefrontal cortex is involved in movement planning and cognitive functions, so the absence of significant Lewy pathology there in patients with clear motor problems indicates that other brain regions or mechanisms may be driving symptoms.

This study also highlights the value of analyzing brain tissue from living patients, rather than relying solely on postmortem samples. Postmortem studies often show widespread Lewy pathology, but those patients may represent a later or different stage of the disease. The Mount Sinai team’s work provides a snapshot of the brain at an earlier surgical time point.

Implications for Treatment

If cortical Lewy pathology is not the primary driver of motor symptoms in many Parkinson’s patients, then treatments targeting these protein clumps may need to be reconsidered. DBS itself works by modulating electrical activity in brain circuits, not by clearing Lewy bodies. The study supports the idea that DBS can be effective even when cortical pathology is minimal.

However, the researchers caution that these findings come from a specific group of patients who were eligible for DBS surgery. The results may not apply to all people with Parkinson’s, especially those with significant cognitive decline or other atypical features.

Limitations and Next Steps

The study is limited by its small sample size and the fact that only the prefrontal cortex was examined. Lewy pathology could still be present in other cortical regions or deeper brain structures. Future research should include broader brain sampling and follow patients over time to see how pathology evolves after DBS.

The Mount Sinai team plans to continue investigating the relationship between clinical symptoms and brain changes, using tissue collected during DBS procedures. This approach could help refine our understanding of Parkinson’s progression and guide more personalized treatments.

Frequently Asked Questions

What is Lewy pathology?

Lewy pathology refers to abnormal clumps of a protein called alpha-synuclein that form inside nerve cells. These clumps, known as Lewy bodies, are a hallmark of Parkinson’s disease and are thought to contribute to cell damage and symptoms.

Why is this finding surprising?

Traditional models of Parkinson’s disease suggest that Lewy pathology spreads from the brainstem to the cortex as the disease progresses. Finding little to no cortical Lewy pathology in patients with advanced motor symptoms challenges that model and suggests other factors may be responsible for symptoms.

Does this mean DBS cures Parkinson’s?

No. Deep brain stimulation is a treatment that helps manage motor symptoms, but it does not cure Parkinson’s disease or stop the underlying pathology. The study simply shows that DBS can be effective even when cortical Lewy pathology is minimal.

This is an original report by Vital Signs Today, informed by reporting from Medical Xpress. Read the original source.

This article is for information only and is not medical advice. See our Medical Disclaimer.